Spartanburg Regional Medical Center Report issue

Academic/Hospital Phase 3

Organization Overview

First Clinical Trial
2007
NCT00438659
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2007

Timeline

NOW
  • Now

Alternative names

Gibbs Regional Cancer Center at Spartanburg Regional Medical Center

Active Ingredients

Drugs in Phase 3 Trials (1)

mometasone (elocon) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Breast Neoplasms (Phase 3)

Carcinoma in Situ (Phase 3)

Dermatitis (Phase 3)

Radiodermatitis (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 1
  • # of Trial APIs: 1